AxoGen, Inc.: Revision history

15 August 2022

• curprev 13:2113:21, 15 August 2022 103.126.60.198 talk 1,674 bytes +11 No edit summary undo

11 August 2022

• curprev 21:0021:00, 11 August 2022 109.180.50.163 talk 1,663 bytes +15 No edit summary undo

2 August 2022

• curprev 23:2123:21, 2 August 2022 >Chris 1,648 bytes +1,648 Created page with "AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of sever..."